STUDY OF PLASMA PENTRAXIN 3 LEVELS AS A NOVEL MARKER VERSUS LIVER STIFFNESS FOR NONALCOHOLIC STEATOHEPATITIS IN EGYPTIAN PATIENTS

STUDY OF PENTRAXIN-3 LEVELS IN EGYPTIAN CIRRHOTIC PATIENTS

Study of Serum Pentraxin-3 Level in Non-alcoholic Fatty Liver Disease and Its Affection by Concomitant Chronic Hepatitis B Virus Infection in Egyptian Patients

Serum Pentraxin 3 as a Biomarker of Hepatocellular Carcinoma in Egyptian Liver Cirrhotic Patients

A study of the Role of 25 Hydroxy-Cholecalciferol Level on Non Alcoholic Fatty Liver Disease (NAFLD) in a Cohort of Egyptian Patients

Diagnostic performance of serum steatosis biomarkers in Prediction of Non Alcoholic Fatty Liver Disease in Adult Asymptomatic Egyptians

STUDY OF VITAMIN D STATUS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

Association between serum level of pentraxin-3 and interleukin-40 with HCC disease in Egypt

Study of risk factors of Metabolic associated Fatty Liver Disease (MAFLD) in Fayoum Governorate

Evaluation of Triglyceride-Glucose Index as a Marker of Hepatic Steatosis and Fibrosis in Egyptian Patients with NAFLD